TP53 and cancer: Moreover, the Asian Cancer Research Group (ACRG) project offers a new molecular classification, including MSI subtype, microsatellite stable with epithelial to mesenchymal transition (MSS/EMT), MSS/TP53 mutant (MSS/TP53+), and MSS/TP53 wild-type (MSS/TP53-) subtypes (4).